SLC35C2 anticorps (C-Term)

N° du produit ABIN6259278

Détail du produit anti-SLC35C2 anticorps

Antigène: SLC35C2 (OVCOV1) (Ovarian Cancer Overexpressed 1 (OVCOV1))

Épitope: C-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SLC35C2 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Specificité: SLC35C2 Antibody detects endogenous levels of total SLC35C2.

Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogène: A synthesized peptide derived from human SLC35C2, corresponding to a region within C-terminal amino acids.

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Date de péremption: 12 months

Détails sur SLC35C2

Antigène: SLC35C2 (OVCOV1) (Ovarian Cancer Overexpressed 1 (OVCOV1))

Autre désignation: SLC35C2 (OVCOV1 Produits)

Sujet:

Description: May play an important role in the cellular response to tissue hypoxia. May be either a GDP-fucose transporter that competes with SLC35C1 for GDP-fucose, or a factor that otherwise enhances the fucosylation of Notch and is required for optimal Notch signaling in mammalian cells.

Gene: SLC35C2

Poids moléculaire: 40 kDa

ID gène: 51006

UniProt: Q9NQQ7